These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8835)

  • 81. Failure of oral thiomalate to act as an alternative to intramuscular gold in rheumatoid arthritis.
    Rudge SR; Perrett D; Kelly M
    Ann Rheum Dis; 1988 Mar; 47(3):224-7. PubMed ID: 2965555
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin.
    Fossgreen J; Kirchheiner B; Petersen FO; Tophoj E; Zachariae E
    Scand J Rheumatol Suppl; 1976; 1976(0):93-8. PubMed ID: 790554
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The use of salsalate for control of long-term musculo-skeletal pain: an open, non-comparative assessment.
    Regalado RG
    Curr Med Res Opin; 1978; 5(6):454-60. PubMed ID: 657829
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
    Deeks JJ; Smith LA; Bradley MD
    BMJ; 2002 Sep; 325(7365):619. PubMed ID: 12242171
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Fentiazac in rheumatoid arthritis: comparison with sulindac and long-term tolerance.
    Bunde B; Deckers Y; Dequeker J
    Curr Med Res Opin; 1983; 8(5):310-4. PubMed ID: 6340972
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies.
    Cordrey LJ
    J Am Geriatr Soc; 1976 Oct; 24(10):440-6. PubMed ID: 61224
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?
    Halla JT; Atchison SL; Hardin JG
    Ann Rheum Dis; 1991 Oct; 50(10):682-4. PubMed ID: 1958090
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diflunisal ('Dolobid') once-a-day in the treatment of rheumatoid arthritis.
    Bocanegra TS; Dicenta C; Carpignano M; Neu DC; Bolognese JA
    Curr Med Res Opin; 1985; 9(8):568-77. PubMed ID: 3161703
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rheumatoid arthritis--anti-inflammatory drugs.
    Paulus HE
    Clin Rheum Dis; 1983 Dec; 9(3):571-80. PubMed ID: 6360513
    [No Abstract]   [Full Text] [Related]  

  • 91. Toxicity of benorylate.
    Hingorani K
    Br Med J; 1973 Feb; 1(5850):418. PubMed ID: 4540242
    [No Abstract]   [Full Text] [Related]  

  • 92. Final report on the cost of treating arthritic disease: comparison between salicylates and nonsalicylate nonsteroidal anti-inflammatory drugs.
    Kolodny AL; Klipper A
    Semin Arthritis Rheum; 1985 Feb; 14(3 Suppl 1):20-4. PubMed ID: 3938874
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term efficacy and toxicity of cyclosporin A + fluocortolone + methotrexate in the treatment of rheumatoid arthritis.
    Pascalis L; Aresu G; Pia G
    Clin Exp Rheumatol; 1999; 17(6):679-88. PubMed ID: 10609066
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Control of morning stiffness in rheumatoid arthritis by high salicylate dosage. Preliminary report.
    Kendall PH; Cahill WJ
    Ann Phys Med; 1967 Feb; 9(1):19-21. PubMed ID: 6017055
    [No Abstract]   [Full Text] [Related]  

  • 95. [Low-dose oral methotrexate in the treatment of rheumatoid polyarthritis].
    Chamot AM; Gerster JC; Van Melle G
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1267-71. PubMed ID: 3175573
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study.
    Yocum DE; Klippel JH; Wilder RL; Gerber NL; Austin HA; Wahl SM; Lesko L; Minor JR; Preuss HG; Yarboro C
    Ann Intern Med; 1988 Dec; 109(11):863-9. PubMed ID: 3190040
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A double-blind study of benorylate and chlormezanone in musculoskeletal disease.
    Berry H; Liyanage SP; Durance RA; Goode JD; Swannell AJ
    Rheumatol Rehabil; 1981 Feb; 20(1):46-9. PubMed ID: 6111837
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity.
    Radner H; Ramiro S; Buchbinder R; Landewé RB; van der Heijde D; Aletaha D
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008951. PubMed ID: 22258995
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A long-term study of benorylate in patients with rheumatoid arthritis.
    Müller-Fassbender H; Schattenkirchner M
    Scand J Rheumatol Suppl; 1975; 13():21-4. PubMed ID: 8835
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Benorylate: a report on 2 years' experience of its use in rheumatoid arthritis and other chronic rheumatic diseases.
    Hingorani K
    Scand J Rheumatol Suppl; 1975; 13():29-32. PubMed ID: 8837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.